Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 12

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 12
---
 of approximately 1,064,846,416.38 shares of Common Stock issuable
upon exercise of the Series Warrants, which consists of (i) an aggregate of approximately 81,911,262.80 shares of Common Stock issuable
upon exercise of 40,000,000 Series A Warrants issued in the Offering (assuming the full exercise of the Series A Warrants at an exercise
price equal to the floor price of $0.0586) and (ii) an aggregate of approximately 982,935,153.58 shares of Common Stock issuable upon
exercise of 40,000,000 Series B Warrants issued in the Offering (assuming (x) the full exercise of the Series B Warrants at an exercise
price equal to the floor price of $0.0586 and (y) all the Series B Warrants are exercised on the “zero exercise price” basis).

<div align='center'>4</div>

Proposal 2 (the “Reverse Stock Split Proposal”):

To approve an amendment to our Amended and Restated Certificate of
Incorporation, as amended (the “Charter”) to effect, at the discretion of the Board but prior to the one-year anniversary
of the date on which the reverse stock split is approved by the Company’s stockholders at the Special Meeting, a reverse stock split
of all of the outstanding shares of our Common Stock at a ratio in the range of 1-for-250 to 1-for-500, with such ratio to be determined
by the board of directors (the “Board”) of the Company in its discretion and included in a public announcement.

Proposal 3 (the “Plan Amendment Proposal”):

To approve the Third Amendment to the Petros Pharmaceuticals, Inc.
Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended, to increase the total number of shares of the Company’s
Common Stock authorized for issuance under such plan by 1,000,000,000, to a total of 1,002,760,000 shares of Common Stock.

Proposal 4 (the “Share Increase Proposal”):

To approve an amendment to the Charter, to increase the number of our authorized shares of Common Stock from 250,000,000 shares to 7,000,000,000 sharesand to make a corresponding
change to the number of authorized shares of capital stock.

Proposal 5 (the “Adjournment Proposal”):

To approve a proposal to adj